Floatz logo

Therapeutic Asset Ratings

9,922 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ligritinib
Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Ligritinib
Cholangiocarcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Ligritinib
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP1CC (43)
Liposomal Curcumin
Plasma Cell Myeloma
University Health Network, TorontoP1CC (43)
Lisaftoclax
Chronic Myeloid Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Lisaftoclax
T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Lisaftoclax
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer CenterP1CC (43)
Lithium, Elemental
Post-Traumatic Stress Disorder
Rakitzi, StavroulaP1CC (43)
Lithium, Elemental
Esophageal Cancer
Cancer Trials IrelandP1CC (43)
Lithium, Elemental
Gastric Neoplasm
Cancer Trials IrelandP1CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Follicular Lymphoma
Fred Hutchinson Cancer CenterP1CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Primary Mediastinal Large B-Cell Lymphoma
Fred Hutchinson Cancer CenterP1CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Diffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer CenterP1CC (43)
Lm-Gucy2C Vaccine
Small Intestine Adenocarcinoma
Thomas Jefferson UniversityP1CC (43)
ln-144
Primary Central Nervous System Lymphoma
Iovance Biotherapeutics, Inc.P1CC (43)
Lonafarnib
Supratentorial Cancer
M.D. Anderson Cancer CenterP1CC (43)
Loperamide
Colitis
M.D. Anderson Cancer CenterP1CC (43)
Loperamide
Uterine Cancer
M.D. Anderson Cancer CenterP1CC (43)
Loxo-260
Thyroid Cancer
Eli Lilly and CompanyP1CC (43)
Loxo-338
Marginal Zone Lymphoma
Eli Lilly and CompanyP1CC (43)
Loxo-338
Mantle Cell Lymphoma
Eli Lilly and CompanyP1CC (43)
Loxo-435
Ureter Neoplasm
Eli Lilly and CompanyP1CC (43)
Loxo-435
Urinary Bladder Neoplasm
Eli Lilly and CompanyP1CC (43)
lp-118
Chronic Myelomonocytic Leukemia
Newave Pharmaceutical IncP1CC (43)
lp-118
Myelodysplastic/Myeloproliferative Neoplasm
Newave Pharmaceutical IncP1CC (43)
Showing 2676 to 2700 of 9,922 assets
PreviousPage 108 of 397Next